Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 586

1.

Opioid Use after Breast-Conserving Surgery: Prospective Evaluation of Risk Factors for High Opioid Use.

Park KU, Kyrish K, Yi M, Bedrosian I, Caudle AS, Kuerer HM, Hunt KK, Miggins MV, DeSnyder SM.

Ann Surg Oncol. 2019 Dec 9. doi: 10.1245/s10434-019-08091-3. [Epub ahead of print]

PMID:
31820211
2.

Staging for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Utility of Incorporating Biologic Factors.

Yi M, Lin H, Bedrosian I, Shen Y, Hunt KK, Chavez-MacGregor M, King TA, Mittendorf EA.

Ann Surg Oncol. 2019 Oct 30. doi: 10.1245/s10434-019-07983-8. [Epub ahead of print]

PMID:
31667721
3.

Challenges in Clinical Trial Implementation: Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC).

Weiss A, Lopez NE, Ward EP, Lee KC, Caudle AS, Dickson-Witmer D, Chang C, Kelly K, Martin LW, Jacobs LK, Hunt KK, Yao K, Blair SL.

Ann Surg Oncol. 2019 Dec;26(13):4364-4371. doi: 10.1245/s10434-019-07807-9. Epub 2019 Oct 17.

PMID:
31625045
4.

Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance).

Al-Refaie WB, Decker PA, Ballman KV, Pisters PWT, Posner MC, Hunt KK, Meyers B, Weinberg AD, Nelson H, Newman L, Tan A, Le-Rademacher JG, Hurria A, Jatoi A.

Ann Surg Oncol. 2019 Dec;26(13):4213-4221. doi: 10.1245/s10434-019-07851-5. Epub 2019 Oct 11.

PMID:
31605327
5.

Excision of both pretreatment marked positive nodes and sentinel nodes improves axillary staging after neoadjuvant systemic therapy in breast cancer.

Simons JM, van Pelt MLMA, Marinelli AWKS, Straver ME, Zeillemaker AM, Pereira Arias-Bouda LM, van Nijnatten TJA, Koppert LB, Hunt KK, Smidt ML, Luiten EJT, van der Pol CC.

Br J Surg. 2019 Nov;106(12):1632-1639. doi: 10.1002/bjs.11320. Epub 2019 Oct 8.

6.

Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer.

Karakas C, Francis AM, Ha MJ, Wingate HF, Meena RA, Yi M, Rasaputra KS, Barrera AMG, Arun B, Do KA, Sahin A, Keyomarsi K, Hunt KK.

Ann Surg. 2019 Aug 20. doi: 10.1097/SLA.0000000000003551. [Epub ahead of print]

PMID:
31436549
7.

A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma.

Lyapichev KA, PiƱa-Oviedo S, Medeiros LJ, Evans MG, Liu H, Miranda AR, Hunt KK, Clemens MW, Stewart JM, Amin MB, Quesada AE, Chai SM, Di Napoli A, Yoga A, Dave SK, Wistuba II, Wu Y, Bueso-Ramos CE, Schlette EJ, Ferrufino-Schmidt MC, Loghavi S, Khoury JD, Young KH, Miranda RN.

Mod Pathol. 2019 Aug 5. doi: 10.1038/s41379-019-0337-2. [Epub ahead of print]

PMID:
31383966
8.

Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.

Armer JM, Ballman KV, McCall L, Ostby PL, Zagar E, Kuerer HM, Hunt KK, Boughey JC.

JAMA Surg. 2019 Jul 17. doi: 10.1001/jamasurg.2019.1742. [Epub ahead of print]

PMID:
31314062
9.

SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.

Alvarado MD, Mittendorf EA, Teshome M, Thompson AM, Bold RJ, Gittleman MA, Beitsch PD, Blair SL, Kivilaid K, Harmer QJ, Hunt KK.

Ann Surg Oncol. 2019 Oct;26(11):3510-3516. doi: 10.1245/s10434-019-07577-4. Epub 2019 Jul 11.

PMID:
31297674
10.

Adherence to surgical and oncologic standards improves survival in breast cancer patients.

Zhao B, Tsai C, Hunt KK, Blair SL.

J Surg Oncol. 2019 Aug;120(2):148-159. doi: 10.1002/jso.25506. Epub 2019 Jun 6.

PMID:
31172534
11.

Redrawing the Lines: The Next Generation of Treatment in Metastatic Breast Cancer.

Savard MF, Khan O, Hunt KK, Verma S.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:e8-e21. doi: 10.1200/EDBK_237419. Epub 2019 May 17. Review.

12.

Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical Trial.

Haffty BG, McCall LM, Ballman KV, Buchholz TA, Hunt KK, Boughey JC.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):174-182. doi: 10.1016/j.ijrobp.2019.04.038. Epub 2019 May 11.

PMID:
31085287
13.

Evolution in practice patterns of axillary management following mastectomy in patients with 1-2 positive sentinel nodes.

Weiss A, Lin H, Babiera GV, Bedrosian I, Shaitelman SF, Shen Y, Kuerer HM, Mittendorf EA, Caudle AS, Hunt KK, Hwang RF.

Breast Cancer Res Treat. 2019 Jul;176(2):435-444. doi: 10.1007/s10549-019-05243-7. Epub 2019 Apr 25.

PMID:
31025270
14.

Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer.

Kettner NM, Vijayaraghavan S, Durak MG, Bui T, Kohansal M, Ha MJ, Liu B, Rao X, Wang J, Yi M, Carey JPW, Chen X, Eckols TK, Raghavendra AS, Ibrahim NK, Karuturi MS, Watowich SS, Sahin A, Tweardy DJ, Hunt KK, Tripathy D, Keyomarsi K.

Clin Cancer Res. 2019 Jul 1;25(13):3996-4013. doi: 10.1158/1078-0432.CCR-18-3274. Epub 2019 Mar 13.

PMID:
30867218
15.

Contemporary management of the axilla in breast cancer.

Nurudeen S, Hunt KK.

Clin Adv Hematol Oncol. 2018 Dec;16(12):823-831. Review.

PMID:
30843891
16.

Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Lamaris GA, Butler CE, Deva AK, Miranda RN, Hunt KK, Connell T, Lipa JE, Clemens MW.

Plast Reconstr Surg. 2019 Mar;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):51S-58S. doi: 10.1097/PRS.0000000000005569.

PMID:
30817556
17.

Surgeon perception versus reality: Opioid use after breast cancer surgery.

Park KU, Kyrish K, Terrell J, Yi M, Caudle AS, Hunt KK, Kuerer HM, Bedrosian I, Thompson A, DeSnyder SM; other members of Department of Breast Surgical Oncology Study Group.

J Surg Oncol. 2019 Jun;119(7):909-915. doi: 10.1002/jso.25395. Epub 2019 Feb 8.

PMID:
30737785
18.

Local Therapy Decisional Regret in Older Women With Breast Cancer: A Population-Based Study.

Advani PG, Lei X, Swanick CW, Xu Y, Shen Y, Goodwin NA, Smith GL, Giordano SH, Hunt KK, Jagsi R, Smith BD.

Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):383-391. doi: 10.1016/j.ijrobp.2019.01.089. Epub 2019 Feb 1.

PMID:
30716524
19.

Differences in Human Leukocyte Antigen Expression Between Breast Implant-Associated Anaplastic Large Cell Lymphoma Patients and the General Population.

Tevis SE, Hunt KK, Miranda RN, Lange C, Butler CE, Clemens MW.

Aesthet Surg J. 2019 Sep 13;39(10):1065-1070. doi: 10.1093/asj/sjz021.

PMID:
30715139
20.

OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients.

Tevis SE, Bassett R, Bedrosian I, Barcenas CH, Black DM, Caudle AS, DeSnyder SM, Fitzsullivan E, Hunt KK, Kuerer HM, Lucci A, Meric-Bernstam F, Mittendorf EA, Park K, Teshome M, Thompson AM, Hwang RF.

Ann Surg Oncol. 2019 Mar;26(3):815-820. doi: 10.1245/s10434-018-7059-4. Epub 2018 Dec 17.

PMID:
30556120
21.

The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer.

Bhardwaj A, Singh H, Trinidad CM, Albarracin CT, Hunt KK, Bedrosian I.

Breast Cancer Res. 2018 Dec 11;20(1):150. doi: 10.1186/s13058-018-1074-z.

22.

An Evaluation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) Staging System for Retroperitoneal Sarcomas Using the National Cancer Data Base (NCDB): Does Size Matter?

Fisher SB, Chiang YJ, Feig BW, Cormier JN, Hunt KK, Torres KE, Roland CL.

Am J Clin Oncol. 2019 Feb;42(2):160-165. doi: 10.1097/COC.0000000000000486.

PMID:
30394881
23.

Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial.

Shaitelman SF, Lei X, Thompson A, Schlembach P, Bloom ES, Arzu IY, Buchholz D, Chronowski G, Dvorak T, Grade E, Hoffman K, Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Amaya DN, Shen Y, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BD.

J Clin Oncol. 2018 Oct 31:JCO1800317. doi: 10.1200/JCO.18.00317. [Epub ahead of print]

24.

Feasibility of fine-needle aspiration for assessing responses to chemotherapy in metastatic nodes marked with clips in breast cancer: A prospective registry study.

Caudle AS, Kuerer HM, Krishnamurthy S, Shin K, Hobbs BP, Ma J, Mittendorf EA, Washington AC, DeSnyder SM, Black DM, Hunt KK, Yang WT.

Cancer. 2019 Feb 1;125(3):365-373. doi: 10.1002/cncr.31825. Epub 2018 Oct 25.

PMID:
30359480
25.

Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.

Keung EZ, Chiang YJ, Cormier JN, Torres KE, Hunt KK, Feig BW, Roland CL.

Cancer. 2018 Dec 1;124(23):4495-4503. doi: 10.1002/cncr.31699. Epub 2018 Oct 14.

26.

Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma.

Keung EZ, Lazar AJ, Torres KE, Wang WL, Cormier JN, Ashleigh Guadagnolo B, Bishop AJ, Lin H, Hunt KK, Bird J, Lewis VO, Patel SR, Wargo JA, Somaiah N, Roland CL.

BMC Cancer. 2018 Sep 24;18(1):913. doi: 10.1186/s12885-018-4829-0.

27.

Imaging Surveillance After Definitive Treatment for Breast Cancer.

Partain NS, Hunt KK.

Ann Surg Oncol. 2018 Dec;25(13):3790-3792. doi: 10.1245/s10434-018-6745-6. Epub 2018 Sep 20. No abstract available.

28.

Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies.

Caruso JA, Duong MT, Carey JPW, Hunt KK, Keyomarsi K.

Cancer Res. 2018 Oct 1;78(19):5481-5491. doi: 10.1158/0008-5472.CAN-18-1235. Epub 2018 Sep 7. Review.

29.

Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial.

Buzdar AU, Suman VJ, Meric-Bernstam F, Leitch AM, Ellis MJ, Boughey JC, Unzeitig GW, Royce ME, Hunt KK.

JAMA Oncol. 2019 Jan 1;5(1):45-50. doi: 10.1001/jamaoncol.2018.3691.

30.

Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition.

Chen X, Low KH, Alexander A, Jiang Y, Karakas C, Hess KR, Carey JPW, Bui TN, Vijayaraghavan S, Evans KW, Yi M, Ellis DC, Cheung KL, Ellis IO, Fu S, Meric-Bernstam F, Hunt KK, Keyomarsi K.

Clin Cancer Res. 2018 Dec 15;24(24):6594-6610. doi: 10.1158/1078-0432.CCR-18-1446. Epub 2018 Sep 4.

PMID:
30181387
31.

Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer.

Lei JT, Shao J, Zhang J, Iglesia M, Chan DW, Cao J, Anurag M, Singh P, He X, Kosaka Y, Matsunuma R, Crowder R, Hoog J, Phommaly C, Goncalves R, Ramalho S, Peres RMR, Punturi N, Schmidt C, Bartram A, Jou E, Devarakonda V, Holloway KR, Lai WV, Hampton O, Rogers A, Tobias E, Parikh PA, Davies SR, Li S, Ma CX, Suman VJ, Hunt KK, Watson MA, Hoadley KA, Thompson EA, Chen X, Kavuri SM, Creighton CJ, Maher CA, Perou CM, Haricharan S, Ellis MJ.

Cell Rep. 2018 Aug 7;24(6):1434-1444.e7. doi: 10.1016/j.celrep.2018.07.009.

32.

Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer.

Parker PA, Peterson SK, Shen Y, Bedrosian I, Black DM, Thompson AM, Nelson JC, DeSnyder SM, Cook RL, Hunt KK, Volk RJ, Cantor SB, Dong W, Brewster AM.

J Clin Oncol. 2018 Sep 1;36(25):2630-2638. doi: 10.1200/JCO.2018.78.6442. Epub 2018 Jul 25.

33.

Incorporating Biologic Factors into the American Joint Committee on Cancer Breast Cancer Staging System: Review of the Supporting Evidence.

Weiss A, King TA, Hunt KK, Mittendorf EA.

Surg Clin North Am. 2018 Aug;98(4):687-702. doi: 10.1016/j.suc.2018.03.005. Epub 2018 May 21. Review.

PMID:
30005768
34.

Satisfaction and Sustainability in a Surgical Career.

Hunt KK, Wingate HF.

Ann Surg Oncol. 2018 Oct;25(10):2785-2789. doi: 10.1245/s10434-018-6577-4. Epub 2018 Jul 10. No abstract available.

35.

The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial.

Rosenkranz KM, Ballman K, McCall L, Kubicky C, Cuttino L, Le-Petross H, Hunt KK, Giuliano A, Van Zee KJ, Haffty B, Boughey JC.

Ann Surg Oncol. 2018 Oct;25(10):2858-2866. doi: 10.1245/s10434-018-6583-6. Epub 2018 Jul 9.

36.

American Society of Breast Surgeons' Practice Patterns After Publication of the SSO-ASTRO-ASCO DCIS Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation.

DeSnyder SM, Hunt KK, Dong W, Smith BD, Moran MS, Chavez-MacGregor M, Shen Y, Kuerer HM, Lucci A.

Ann Surg Oncol. 2018 Oct;25(10):2965-2974. doi: 10.1245/s10434-018-6580-9. Epub 2018 Jul 9.

PMID:
29987598
37.

Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy.

Armer JM, Ballman KV, McCall L, Armer NC, Sun Y, Udmuangpia T, Hunt KK, Mittendorf EA, Byrd DR, Julian TB, Boughey JC.

Support Care Cancer. 2019 Feb;27(2):495-503. doi: 10.1007/s00520-018-4334-7. Epub 2018 Jul 6.

PMID:
29980907
38.

Multidisciplinary Intraoperative Assessment of Breast Specimens Reduces Number of Positive Margins.

Tevis SE, Neuman HB, Mittendorf EA, Kuerer HM, Bedrosian I, DeSnyder SM, Thompson AM, Black DM, Scoggins ME, Sahin AA, Hunt KK, Caudle AS.

Ann Surg Oncol. 2018 Oct;25(10):2932-2938. doi: 10.1245/s10434-018-6607-2. Epub 2018 Jun 26.

39.

Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis.

Valachis A, Mamounas EP, Mittendorf EA, Hayashi N, Ishitobi M, Natoli C, Fitzal F, Rubio IT, Tiezzi DG, Shin HC, Anderson SJ, Hunt KK, Matsuda N, Ohsumi S, Totomi A, Nilsson C.

Cancer. 2018 Jul 15;124(14):2923-2930. doi: 10.1002/cncr.31518. Epub 2018 May 3.

40.

Nongastrointestinal Stromal Tumor Spindle Cell Sarcomas of the Colon or Rectum.

Ikoma N, Roland CL, Cormier JN, Chiang YJ, Torres KE, Hunt KK, You YN, Feig BW.

Am Surg. 2018 Apr 1;84(4):570-575.

PMID:
29712608
41.

Breast Implant-Associated Anaplastic Large Cell Lymphoma With Bone Marrow Involvement.

Loghavi S, Medeiros LJ, Javadi S, Lin P, Khoury JD, Nastoupil L, Hunt KK, Clemens MW, Miranda RN.

Aesthet Surg J. 2018 Jun 13;38(7). doi: 10.1093/asj/sjy097. No abstract available.

PMID:
29635424
42.

Salvage Surgery for Recurrent Retroperitoneal Well-Differentiated Liposarcoma: Early Reoperation may not Provide Benefit.

Ikoma N, Roland CL, Torres KE, Chiang YJ, Wang WL, Somaiah N, Mann GN, Hunt KK, Cormier JN, Feig BW.

Ann Surg Oncol. 2018 Aug;25(8):2193-2200. doi: 10.1245/s10434-018-6417-6. Epub 2018 Mar 8.

43.

Long-term Patient-Reported Outcomes in Older Breast Cancer Survivors: A Population-Based Survey Study.

Swanick CW, Lei X, Xu Y, Shen Y, Goodwin NA, Smith GL, Giordano SH, Hunt KK, Jagsi R, Shaitelman SF, Peterson SK, Smith BD.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):882-890. doi: 10.1016/j.ijrobp.2017.11.047. Epub 2017 Dec 9.

44.

Comparative Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Systems for Soft Tissue Sarcoma of the Trunk and Extremities.

Fisher SB, Chiang YJ, Feig BW, Cormier JN, Hunt KK, Torres KE, Roland CL.

Ann Surg Oncol. 2018 May;25(5):1126-1132. doi: 10.1245/s10434-018-6378-9. Epub 2018 Feb 21.

45.

Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy.

Roland CL, Bednarski BK, Watson K, Torres KE, Cormier JN, Wang WL, Lazar AJ, Somaiah N, Hunt KK, Feig BW.

J Surg Oncol. 2018 Apr;117(5):879-885. doi: 10.1002/jso.24988. Epub 2018 Feb 15.

46.

Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).

Le-Petross HT, McCall LM, Hunt KK, Mittendorf EA, Ahrendt GM, Wilke LG, Ballman KV, Boughey JC.

AJR Am J Roentgenol. 2018 Mar;210(3):669-676. doi: 10.2214/AJR.17.18295. Epub 2018 Jan 30.

47.

Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy.

Keung EZ, Tsai JW, Ali AM, Cormier JN, Bishop AJ, Guadagnolo BA, Torres KE, Somaiah N, Hunt KK, Wargo JA, Lazar AJ, Wang WL, Roland CL.

Oncoimmunology. 2017 Oct 31;7(2):e1385689. doi: 10.1080/2162402X.2017.1385689. eCollection 2018.

48.

Concomitant organ resection does not improve outcomes in primary retroperitoneal well-differentiated liposarcoma: A retrospective cohort study at a major sarcoma center.

Ikoma N, Roland CL, Torres KE, Chiang YJ, Wang WL, Somaiah N, Mann GN, Hunt KK, Cormier JN, Feig BW.

J Surg Oncol. 2018 May;117(6):1188-1194. doi: 10.1002/jso.24951. Epub 2017 Dec 11.

PMID:
29228466
49.

Validation Study of the American Joint Committee on Cancer Eighth Edition Prognostic Stage Compared With the Anatomic Stage in Breast Cancer.

Weiss A, Chavez-MacGregor M, Lichtensztajn DY, Yi M, Tadros A, Hortobagyi GN, Giordano SH, Hunt KK, Mittendorf EA.

JAMA Oncol. 2018 Feb 1;4(2):203-209. doi: 10.1001/jamaoncol.2017.4298.

50.

Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma.

Keung EZ, Chiang YJ, Voss RK, Cormier JN, Torres KE, Hunt KK, Feig BW, Roland CL.

Eur J Surg Oncol. 2018 Jan;44(1):170-177. doi: 10.1016/j.ejso.2017.11.014. Epub 2017 Nov 27.

Supplemental Content

Support Center